| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.083 | 0.01 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.01 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.01 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.085 | 0.01 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.089 | 0.01 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.079 | 0.01 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.01 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.01 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | -0.087 | 0.02 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.02 |